Seems like this company cant decide what it is. They are talking of one or maybe more new deals before eofy and potentially as big as janssen, and also progress with at least a couple of the existing deals- then they start talking about being bought out. Surely any potential buyout will put the brakes on any new deals and make current collaborators think again? Unless they are bought out by some bio fund that just lets them carry on with variius deals and clients. Wish i knew what the hell is going on here.
Ann: Phylogica Engages Financial Advisor , page-8
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.8¢ | 9.9¢ | $290.0K | 2.818M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 537039 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 87446 | 2 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |